Clinical Trial Update: Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating extended-release tacrolimus (Advagraf) in adults with severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: UMC Utrecht | Conditions: Atopic Dermatitis | Status: COMPLETED